Prevalence of COPD in Copenhagen

Respiratory Medicine

Volumn 105, Issue 3, 2011, Pages 410-417

  Fabricius, Peder ^a   Løkke, Anders ^b   Marott, Jacob Louis ^c   Vestbo, Jørgen ^a,d   Lange, Peter ^a,c  

^a HVIDOVRE HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

BMI; Co morbidity; COPD; GOLD classification; Prevalence; Pulmonary medication

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; COMORBIDITY; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GROUPS BY AGE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING;

CARDIOVASCULAR DISEASES; DENMARK; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 79151474595     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.09.019     Document Type: Article

References (38)

1. A. Løkke, P. Lange, H. Scharling, P. Fabricius, and J. Vestbo Developing COPD a 25 year follow up study of the general population Thorax 61 2006 935 939 (Pubitemid 44787161)
2. R.A. Pauwels, and K.F. Rabe Burden and clinical features of chronic obstructive pulmonary disease (COPD) Lancet 364 2004 613 620
3. B.R. Celli, W. MacNee, and A. Agusti Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur Respir J 23 2004 932 946
4. C.J. Murray, and A.D. Lopez Alternative projections of mortality and disability by cause 1990-2020: global Burden of Disease Study Lancet 349 1997 1498 1504
5. K.F. Rabe, S. Hurd, and A. Anzueto Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary Am J Respir Crit Care Med 176 2007 532 555
6. A.S. Buist, M.A. Mcburnie, and W.M. Vollmer International variation in the prevealence of COPD (The BOLD Study): a population-based prevalence study Lancet 370 2007 741 750
7. A. Lindberg, A.C. Jonsson, E. Rönmark, R. Lundgren, L.G. Larsson, and B. Lundbäck Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctors's diagnosis, symptoms, age, gender and smoking habits Respiration 72 2005 471 479
8. M.B. Menezes, R. Perez-Padilla, and J.R.B. Jardim Chronic obstructive pulmonary disease in five Latin American cities (the Platino study): a prevalence study Lancet 366 2005 1875 1881
9. A. Lindberg, A. Bjerg-Backlund, E. Rönmark, L.G. Larsson, and B. Lundbäck Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the obstructive lung disease in Northern Sweden studies Respir Med 100 2006 264 272
10. E. Murtaugh, L. Heaney, and J. Gingles The prevalence of obstructive lung disease in a general population sample: the NICECOPD study Eur J Epidemiol 20 2005 443 453
11. D.S. Kim, Y.S. Kim, and K.S. Jung Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey Am J Respir Crit Care Med 172 2005 842 847
12. F. Cetinkaya, I. Gulmez, T. Aydin, Y. Ozturk, M. Ozesmi, and R. Demir Prevalence of chronic bronchitis and associated risk factors in a rural area of Kayseri, Central Anatolia, Turkey Monaldi Arch Chest Dis 55 2000 189 193
13. R. De La Fuente Cid, and F.J. Gonzalez Barcala COPD, a public health problem Rev Clin Esp 206 2006 442 443
14. A.M. Menezes, C.G. Victora, and M. Rigatto Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: a population-based study Thorax 49 1994 1217 1221
15. Y. Fukuchi, M. Nishimura, and M. Ichinose COPD in Japan: the Nippon COPD Epidemiology study Respirology 9 4 2004 Nov 458 465
16. A.D. Mohangoo, M.W. van der Linden, F.G. Schellevis, and H. Raat Prevalence estimates of asthma or COPD from a health interview survey and from general practitioner registration: what's the difference? Eur J Public Health 16 1 2006 Feb 101 105
17. B.R. Celli, C.G. Cote, and J.M. Marin The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 2004 1005 1012
18. Spirometry-a recommendation (in Danish) 1986 Danish Respiratory Society Copenhagen
19. K. Torén, J. Brisman, and B. Järvholm Asthma and asthma-like symptoms in adults assessed by questionnaires Chest 104 1993 600 608
20. C.M. Fletcher Standardized questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the aetiology of chronic bronchitis (MRC breathlessness score) BMJ 2 1960 241 243
21. L.A. Goodman On simultaneous confidence intervals for multinomial proportions Technometrics 7 1965 247 254
22. Home page with specifications on SPSS 12.0 www.spss.com/press/template- view.cfm?PR-ID=614 [accessed 05.05.09]
23. P. Lange, J. Parner, E. Prescott, and J. Vestbo Chronic bronchitis in an elderly population Age Ageing 32 2003 636 642
24. Home page from The Danish National Board of Health with statistics regarding smoking, alcohol and drugs www.sst.dk/publ/publ2003/statistik2003.pdf [accessed 08.01.09]
25. J.G. Hansen, L. Pedersen, K. Overvad, Ø Omland, H.K. Jensen, and H.T. Sørensen The prevalence of chronic obstructive pulmonary disease among danes 45-84 years: population-based study J Chonic obstructive Pulm Dis 5 2008 347 352
26. A. Johannessen, E.R. Omenaas, P.S. Bakke, and A. Gulsvik Implications of reversibility testing on prevalence and risk factors for chronic obstructive disease: a community study Thorax 60 2005 842 847
27. P. Lange Development and prognosis of chronic obstructive pulmonary disease with special reference to the role of tobacco smoking Dan Med Bull 39 1992 30 48
28. M. Kjøller, and H. Thoning Characteristics of non-response in the danish health interview surveys Eur J Public Health 15 5 1987-1994 528 535
29. Gundgaard J, Ekholm O, Hansen EH, Rasmussen NK. The effect of non-response on estimates of health care utilisation: linking health surveys and registers. Eur J Public Health, 18, 2, 189-194.
30. E.P. Rönmark, L. Ekerljung, J. Lötvall, K. Torn, E. Rönmark, and B. Lundbäck Large sacle questionnaire survey on respiratory health in Sweden: effects of late and non-response Respir Med 103 12 2009 Dec 1807 1815
31. H. Andreassen, and J. Vestbo Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective Eur Respir J 22 Suppl. 46 2003 2 4
32. E.F.M. Wouters, E.C. Creutzberg, and A.M.W.J. Schols Systemic effects in COPD Chest 121 2002 127 130
33. T. Oga, K. Nishimura, M. Tsukino, T. Hajiro, and M. Mishima Dyspnoea with activities of daily living versus peak dyspnoea during exercise in male patients with COPD Respir Med 100 6 2006 Jun 965 971
34. P.S. Burge, P.M. Calverley, P.W. Jones, S. Spencer, J.A. Anderson, and T.K. Maslen Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial BMJ 320 2000 1297 1303
35. P.M. Calverley, J.A. Anderson, B. Celli TORCH investigators Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 2007 775 789
36. K.F. Rabe Improving dyspnea in chronic obstructive pulmonary disease: optimal treatment strategies Proc Am Thorac Soc 3 2006 270 275
37. C. Janson, T. Gislason, and C. Suppli Ulrik Characteristics of hospitalised patients with COPD in the Nordic countries Respir Med 100 Suppl. A 2006 10 16
38. D.D. Sin, N.R. Anthonisen, J.B. Soriano, and A.G. Agusti Mortality in COPD: role of comorbidities Eur Respir J 28 2006 Dec 1245 1257